Phenotypic differences between esophageal and gastric intestinal metaplasia

作者: M Blanca Piazuelo , Salima Haque , Alberto Delgado , Joanna X Du , Fred Rodriguez

DOI: 10.1038/MODPATHOL.3800016

关键词: CytokeratinKeratin 20Mucin 2Helicobacter pyloriMetaplasiaStomachEsophagusPathologyIntestinal metaplasiaInternal medicineMedicineGastroenterology

摘要: Intestinal metaplasia is a cancer precursor in the esophagus and stomach. Marked differences exist between carcinogenic processes two locations terms of natural history clinical significance. We investigated biopsies from 52 patients with Barrett's 50 gastric intestinal an attempt to throw light on their pathogenic processes. Morphologic characteristics, presence Helicobacter pylori (H. pylori), markers differentiation, inflammation, proliferation were evaluated by histochemical immunohistochemical techniques. The area covered incomplete type proportion sulfomucins significantly higher than Immunoreactivity MUC1, MUC2, MUC5AC, Das-1, cytokeratins 7 20, inducible nitric oxide synthase cyclooxygenase-2 antibodies was also greater metaplasia. In metaplasia, Das-1 cytokeratin restricted areas Cell (Ki-67) H. absent all esophagus, while it present 70% Our observations made clear that shares some phenotypic characteristics leading us suggest both could arise response injuries eventual potential. However, progression more advanced lesions be modulated nature insult.

参考文章(93)
Milosavljevic T, Tzardi M, Delides G, Mouzas Ia, Sganzos M, Kanavaros P, Zois M, Jovanovic I, Micev M, Pesko P, Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction. Histology and Histopathology. ,vol. 17, pp. 445- 454 ,(2002) , 10.14670/HH-17.445
Edna B. Prophet, Laboratory methods in histotechnology American Registry of Pathology, Armed Forces Institute of Pathology. ,(1992)
Tito Collazos, Elizabeth Fontham, William Haenszel, Guillermo Zarama, Steven Tannenbaum, Bernardo Ruiz, Carlos Cuello, Diego Zavala, Pelayo Correa, Gastric Precancerous Process in a High Risk Population: Cohort Follow-up Cancer Research. ,vol. 50, pp. 4737- 4740 ,(1990)
M Sobrinho-Simões, P Correa, E Garcia, F Carneiro, C A Reis, L David, H Clausen, U Mandel, C de Bolós, Intestinal Metaplasia of Human Stomach Displays Distinct Patterns of Mucin (MUC1, MUC2, MUC5AC, and MUC6) Expression Cancer Research. ,vol. 59, pp. 1003- 1007 ,(1999)
Hye Seung Lee, Hyeon Kook Lee, Hee Sung Kim, Han Kwang Yang, Yong Il Kim, Woo Ho Kim, None, MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer. ,vol. 92, pp. 1427- 1434 ,(2001) , 10.1002/1097-0142(20010915)92:6<1427::AID-CNCR1466>3.0.CO;2-L
Cristina Carrato, Cristina Balague, Carme De Bolos, Eduardo Gonzalez, Gemma Gambus, Josep Planas, Jean Marc Perini, David Andreu, Francisco X. Real, Differential apomucin expression in normal and neoplastic human gastrointestinal tissues Gastroenterology. ,vol. 107, pp. 160- 172 ,(1994) , 10.1016/0016-5085(94)90073-6
Pelayo Correa, A Human Model of Gastric Carcinogenesis Cancer Research. ,vol. 48, pp. 3554- 3560 ,(1988)
W. W. Franke, J. Laufer, R. Moll, A. Löwe, Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. American Journal of Pathology. ,vol. 140, pp. 427- 447 ,(1992)
Peiguo Chu, Emerald Wu, Lawrence M Weiss, Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases Modern Pathology. ,vol. 13, pp. 962- 972 ,(2000) , 10.1038/MODPATHOL.3880175